| Elizabeth Ireland, APRN | |
|
230 W Wade Hampton Blvd, Greer, SC 29650-1655 | |
| (864) 968-9144 | |
| Not Available |
| Full Name | Elizabeth Ireland |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 230 W Wade Hampton Blvd, Greer, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104570274 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 25741 (South Carolina) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Doctors Care, Pa | 6204731300 | 187 |
News Archive
Today, the National Association of Boards of Pharmacy issued a report discussing the importance of international collaboration in the fight against illegal online drug sellers. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: October 2015, there is widespread agreement among multiple countries that Internet sales of medicinal products pose a health risk to their citizens.
Dr. Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year federal grant just over $2 million to study how inflammation and altered gut microbiota, the microorganisms living in the intestine, influence the development of a group of diseases referred to as metabolic syndrome.
The Wellcome Trust, one of the world's largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world's most neglected tropical diseases.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.
› Verified 8 days ago
| Entity Name | Doctors Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366499048 PECOS PAC ID: 6204731300 Enrollment ID: O20040112000069 |
News Archive
Today, the National Association of Boards of Pharmacy issued a report discussing the importance of international collaboration in the fight against illegal online drug sellers. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: October 2015, there is widespread agreement among multiple countries that Internet sales of medicinal products pose a health risk to their citizens.
Dr. Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year federal grant just over $2 million to study how inflammation and altered gut microbiota, the microorganisms living in the intestine, influence the development of a group of diseases referred to as metabolic syndrome.
The Wellcome Trust, one of the world's largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world's most neglected tropical diseases.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Ireland, APRN 729 Terrace Creek Dr, Duncan, SC 29334-8943 Ph: (864) 373-4040 | Elizabeth Ireland, APRN 230 W Wade Hampton Blvd, Greer, SC 29650-1655 Ph: (864) 968-9144 |
News Archive
Today, the National Association of Boards of Pharmacy issued a report discussing the importance of international collaboration in the fight against illegal online drug sellers. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: October 2015, there is widespread agreement among multiple countries that Internet sales of medicinal products pose a health risk to their citizens.
Dr. Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year federal grant just over $2 million to study how inflammation and altered gut microbiota, the microorganisms living in the intestine, influence the development of a group of diseases referred to as metabolic syndrome.
The Wellcome Trust, one of the world's largest medical charities, has awarded £8.1 million over 5 years to a team of six scientists at the University of Dundee to help discover new drugs to treat some of the world's most neglected tropical diseases.
PositiveID Corporation, in conjunction with its development partner RECEPTORS LLC, announced today that the companies have achieved a milestone in the development of their in vivo glucose-sensing RFID microchip to detect glucose levels in the body. The companies have completed the synthesis of a new chemical building block that will serve as the anchor of their next generation of Combinatorial Artificial Receptor (CARA™) surfaces for the sensing system component of the implantable glucose sensor.
Oceana Therapeutics, a global company focused on acquiring, developing and commercializing best-in-class specialty therapeutics, today announced the publication of results from a randomized-controlled clinical trial of the bulking agent, NASHA DX, a dextranomer suspended in stabilized, which was injected into the submucosa of the anal canal in patients with fecal incontinence.
› Verified 8 days ago
Mrs. Kristin Nicole Tolley, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3308 Brushy Creek Rd, Greer, SC 29650 Phone: 864-752-2000 | |
Dr. Wanda Sexton Samake, DNP, PMHNP, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 300 John St Unit 5b, Greer, SC 29651 Phone: 864-990-5664 Fax: 864-990-5674 | |
Robyn White, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 119 Chandler Crest Ct, Greer, SC 29651 Phone: 917-561-8382 | |
Heather Ann Traynham, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2755 S Highway 14 Ste 2200, Greer, SC 29650 Phone: 864-849-9555 Fax: 864-849-9556 | |
Melissa Hope Suttell, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 206a S Main St, Greer, SC 29650 Phone: 864-989-0230 Fax: 864-334-1880 | |
Dr. Patricia Banke, DNP-PMHNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 430 Cox Rd, Greer, SC 29651 Phone: 864-872-5720 |